CenterPoints: Ana Maria Arbelaez, MD talks about her research in children with type 1 diabetes within this Center.

Musculoskeletal and metabolic diseases are a leading cause of disability in children and are frequently associated with genetic abnormalities that alter their normal growth and development. Recent advances have led to the discoveries of some genetic defects involved in several musculoskeletal and metabolic diseases, including those that cause alterations in the skeleton (e.g. scoliosis, clubfoot), undergrowth syndromes (e.g. celiac disease) and overgrowth syndromes (e.g. Beckwith Weidman disease).

The Center for Musculoskeletal and Metabolic Diseases will accelerate research through, for example,the development of several strategies including international patient registries and DNA banks for selected pediatric musculoskeletal and metabolic diseases that will enable scientists to identify the genes responsible for these diseases and develop approaches to preventative measures within the next decade.

Additional work will be focused on the biology of tissue and organ growth, development and regeneration that can lead to novel approaches to regenerative medicine and progenitor cell therapy.